tiprankstipranks

Joseph Wender Insider Profile

11 Followers
Joseph Wender, Director at Ionis Pharmaceuticals, holds 128.08K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 48.87K shares in Outfront Media (Ticker: OUT). Most recently, Joseph Wender Bought ― shares of Ionis Pharmaceuticals on May 13, 2024 for an estimated value of 568.48K.
tipranks
Joseph Wender

Joseph Wender
Ionis Pharmaceuticals (IONS)
Director

Ranked #5,735 out of 98,909 Corporate Insiders

Profitable Transactions

73%
8 out of 11 Profitable Transactions

Average Return

+25.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
86.73%
13.27%
A breakdown of Joseph Wender's holdings

Insider Roles

Ionis Pharmaceuticals
(IONS)
Director
Outfront Media
(OUT)
Director
Roles that Joseph Wender holds in companies

Most Profitable Insider Trade

Stock:
Ionis Pharmaceuticals
(IONS)
Rating:Informative Buy
Date:Jul 19, 2018 - Jul 19, 2019
Return:+74.90%
The most profitable trade made by Joseph Wender

Joseph Wender's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ionis Pharmaceuticals
May 13, 2024
Director
Informative Buy
568.48K
$4.90M
Outfront Media
Jun 08, 2023
Director
Uninformative Buy
$750.14K
List of latest transactions for each holding click on a transaction to see Joseph Wender's performance on stock

Joseph Wender insider profile FAQ

What is the percentage of profitable transactions made by Joseph Wender?
The percentage of profitable transactions made by Joseph Wender is 73%.
    What is the average return per transaction made by Joseph Wender?
    The average return per transaction made by Joseph Wender is 25.60%.
      What stocks does Joseph Wender hold?
      Joseph Wender holds: IONS, OUT stocks.
        What was Joseph Wender’s latest transaction?
        Joseph Wender latest transaction was an Informative Buy of $568.48K.
          What was Joseph Wender's most profitable transaction?
          Joseph Wender’s most profitable transaction was an Informative Buy of IONS stock on July 19, 2018. The return on the trade was 74.90%.
            What is Joseph Wender's role in Ionis Pharmaceuticals?
            Joseph Wender's role in Ionis Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.